Indefinite Delivery Contract 75F40121D00012

Award Date 4/28/21
Last Date to Order 4/29/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Health and Human Services Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) to Biomerieux Inc., a global leader in in vitro diagnostics, with a ceiling value of $2,000,000. The contract provides the FDA with access to Biomerieux's specialized diagnostic platforms, reagents, and test kits to support the agency's medical device testing, pathogen detection, and clinical laboratory operations. Through a series of firm-fixed-price delivery orders...
This federal Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Biomerieux Inc. The contract has a ceiling value of $2,703,976 and a period of performance from July 2010 to July 2015. Biomerieux, through its Biomerieux, Inc. division, is a global leader in in vitro diagnostics and specializes in microbiological testing solutions. Under this IDC, Biomerieux is providing the FDA...
This indefinite delivery contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Biomerieux Inc., a global leader in in vitro diagnostics. The $640,000 single-award IDC facilitates the continued procurement of Biomerieux's specialized clinical diagnostic products and services to meet the FDA's testing needs. Under this IDC, Biomerieux has received a series of firm-fixed-price delivery orders to provide the FDA with a variety of its proprietary...
This indefinite delivery contract with the Food and Drug Administration (FDA) awarded to American Biomedical Group Inc., a small business, provides for the maintenance and repair of scientific instruments used across various FDA components including the Center for Drug Evaluation and Research (CDER), the Center for Food Safety and Applied Nutrition (CFSAN), the Office of Regulatory Affairs (ORA), and others. The contract has a total ceiling value of $20 million and was awarded on September 14,...
The Department of Health and Human Services' Food and Drug Administration (HHS FDA) awarded a single-award indefinite delivery contract to Laboratory Equipment Service, LLC, a self-certified small disadvantaged business, to provide operations and maintenance services for specialized laboratory equipment and infrastructure at FDA facilities. The contract has a potential value of $22,109,440.02 and a period of performance through March 2027. Under this IDV and associated delivery orders,...
This federal contract IDV is a $2.5 million single-award Indefinite Delivery Contract awarded by the Food and Drug Administration (FDA) to Remel Inc., a subsidiary of Thermo Fisher Scientific. The contract is for the provision of various Remel supplies compatible with Sensititre equipment to support the FDA's National Antimicrobial Resistance Monitoring System (NARMS) program and other regulatory science initiatives across multiple delivery locations. The contract has a period of performance...
The Department of Health and Human Services Food and Drug Administration awarded Laboratory Equipment Service, LLC an indefinite delivery contract with a potential value of $4,969,737.20 to provide above standard equipment maintenance services. No set-aside was used for this contract. Task orders issued against this IDV include maintenance and repair services for air transfer systems, data center trace circuits, laboratory facilities, and installation of temperature control equipment. Task order...
The U.S. Food and Drug Administration (FDA) awarded a $50 million single-award indefinite delivery contract to Laboratory Equipment Service, LLC, a self-certified small disadvantaged business, to provide preventative maintenance, repair, and certification services for specialized laboratory equipment and infrastructure at the FDA's White Oak Campus in Silver Spring, Maryland. The contract has a 100% small business set-aside and a period of performance through March 2025. Through this contract...
The Food and Drug Administration awarded a single-award Indefinite Delivery Indefinite Quantity contract to Mettler-Toledo LLC to provide calibration and preventative maintenance services for laboratory instruments. With a potential value of $600,000, this firm-fixed price ID/IQ contract enables the issuance of delivery orders for services at eleven FDA laboratory locations through February 2028. A $104,147 delivery order to Mettler-Toledo LLC supports services to be performed in Irvine,...
This indefinite delivery contract was awarded by the Department of the Army Medical Command to Biomerieux Inc., a global leader in in vitro diagnostics and microbiology testing solutions. The contract has a potential value of $3,115,077.60 and facilitates the continued procurement of Biomerieux's proprietary clinical diagnostic platforms, reagents, and services to meet federal testing needs. The task orders issued to date have been for the company's SENSI CARD product, a firm-fixed-price,...
  • 75F40121D00012
    Indefinite Delivery Contract
  • 4
    Federal Contract Awards

The Federal Indefinite Delivery Contract 75F40121D00012 was awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Biomerieux Inc., a manufacturer of in-vitro diagnostic solutions. The contract, with a ceiling value of $1,975,291.65, is for the provision of preventive maintenance, annual calibrations, and equipment upgrades for the FDA's fleet of Vitek and Vidas laboratory instruments used in their Office of Regulatory Affairs (ORA) and Office of Regulatory Science (ORS) facilities.

The contract includes several firm-fixed price delivery orders to date, valued at $10,402.64, $344,480.44, $326,934.76, and $309,570.76, for maintenance and repair services to be performed at various FDA locations, including Jamaica, NY; Winchester, MA; Takoma Park, MD; and Calverton, MD. The contract has an overall period of performance through April 29, 2026, with individual delivery orders covering shorter durations. No set-aside designations were used for this procurement. The contract aims to ensure the FDA's critical laboratory diagnostic equipment remains properly calibrated and functional to support the agency's health and safety mission.

Generated 5/7/25, 9:54 AM